Renal manifestations in adult-onset Still’s disease: a systematic review

Poonam Arya1, Erica Marnet2, Madhumitha Rondla3, Jia Wei Tan4, Dileep Unnikrishnan5, Gregory K. Buller6
1Yale New Haven Health/Bridgeport Hospital, 267 Grant St, Bridgeport, CT, 06610, USA
2Department of Internal Medicine, Yale New Haven Health, Bridgeport Hospital, Bridgeport, USA
3Department of Internal Medicine, Texas Tech University, El Paso, USA
4Department of Nephrology, Stanford School of Medicine, Stanford, USA
5Department of Internal Medicine, Yale New Haven Health, Stamford, USA
6Internal Medicine/Nephrology, Yale New Haven Health, Bridgeport Hospital, Bridgeport, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P (2021) Adult-onset Still’s disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum 51(4):858–874. https://doi.org/10.1016/j.semarthrit.2021.06.004

Still GF (1897) On a Form of Chronic Joint Disease in Children. Med Chir Trans 80(47–60):49

Ansell BM, Bywaters EG (1959) Prognosis in Still’s disease. Bull Rheum Dis 9(9):189–192

Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30(2):121–133. https://doi.org/10.1136/ard.30.2.121

Peckham D, Scambler T, Savic S, McDermott MF (2017) The burgeoning field of innate immune-mediated disease and autoinflammation. J Pathol 241(2):123–139. https://doi.org/10.1002/path.4812

Szekanecz Z, McInnes IB, Schett G, Szamosi S, Benko S, Szucs G (2021) Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol 17(10):585–595. https://doi.org/10.1038/s41584-021-00652-9

Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, Rozenberg S, Piette JC, Bourgeois P (2002) Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81(3):194–200. https://doi.org/10.1097/00005792-200205000-00003

Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19(3):424–430

Feng J, Meir L, Ghaw O (2023) Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease. Rheumatol Adv Pract. https://doi.org/10.1093/rap/rkad046

Oh YB, Bae SC, Jung JH, Kim TH, Jun JB, Jung SS, Lee IH, Yoo DH, Park MH, Kim SY (2000) Secondary renal amyloidosis in adult onset Still’s disease: case report and review of the literature. Korean J Intern Med 15(2):131–134. https://doi.org/10.3904/kjim.2000.15.2.131

Wendling D, Humbert PG, Billerey C, Fest T, Dupond JL (1991) Adult onset Still’s disease and related renal amyloidosis. Ann Rheum Dis 50(4):257–259. https://doi.org/10.1136/ard.50.4.257

Delplanque M, Pouchot J, Ducharme-Benard S, Fautrel BJ, Benyamine A, Daniel L, Gendre T, Grateau G, Georgin-Lavialle S (2020) AA amyloidosis secondary to adult onset Still’s disease: About 19 cases. Semin Arthritis Rheum 50(1):156–165. https://doi.org/10.1016/j.semarthrit.2019.08.005

Ishii T, Sasaki T, Muryoi T, Murai C, Hatakeyama A, Oosaki H, Yusa A, Kawanami T, Yoshinaga K (1993) Systemic Amyloidosis in a Patient with Adult Onset Still’s Disease. Intern Med 32(1):50–52. https://doi.org/10.2169/internalmedicine.32.50

Serratrice J, Granel B, Disdier P, Weiller P-J, Dussol B (2003) Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still’s disease. Am J Med. https://doi.org/10.1016/j.amjmed.2003.04.001

Amemori S, Iwakiri R, Endo H, Ootani A, Ogata S, Noda T, Tsunada S, Sakata H, Matsunaga H, Mizuguchi M, Ikeda Y, Fujimoto K (2006) Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J Gastroenterol 41(5):444–449. https://doi.org/10.1007/s00535-006-1792-3

Kishida D, Okuda Y, Onishi M, Takebayashi M, Matoba K, Jouyama K, Yamada A, Sawada N, Mokuda S, Takasugi K (2011) Successful tocilizumab treatment in a patient with adult-onset Still’s disease complicated by chronic active hepatitis B and amyloid A amyloidosis. Mod Rheumatol 21(2):215–218. https://doi.org/10.1007/s10165-010-0365-8

Rivera F, Gill CM, Gill MT, Batlle-Gualda E (1997) Vascular renal AA amyloidosis in adult Still's disease. In: 8 ed. Oxford University Press, pp 1714–1716

Muraviev Y, Alekseeva A, Radenska-Lopovok S (2015) AB0405 A Case Report with Clinical and Histopathological Regression of AA-Amyloidosis and Remission of Adult Onset Still’s Disease. Ann Rheum Dis 74(Suppl 2):1029–1029. https://doi.org/10.1136/annrheumdis-2015-eular.6091

El Karoui K, Karras A, Gt L, Charles P, Arlet JBT, Jacquot C, Orssaud C, Nochy D, Pouchot J (2009) Thrombotic microangiopathy and Purtscher-like retinopathy associated with adult-onset Still’s disease: A role for glomerular vascular endothelial growth factor? Arthr Rheumat 61(11):1609–1613. https://doi.org/10.1002/art.24826

Faruqi MA, Babar L, Ashraf O, Naddour M (2019) 499: first of its kind: atypical hemolytic uremic syndrome triggered by adult-onset still disease. Crit Care Med 47(1 suppl 1):230–230. https://doi.org/10.1097/01.ccm.0000551251.75285.37

Khattab A, Yellala A, Mamadgi J, Patruni S, Kaplan R (2019) Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still’s Disease. J Hematol 8(2):64–67

Masuyama A, Kobayashi H, Kobayashi Y, Yokoe I, Sugimura Y, Maniwa K, Sato H, Ishida T, Hatanaka Y (2013) A case of adult-onset Still’s disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema. Mod Rheumatol 23(2):379–385. https://doi.org/10.1007/s10165-012-0650-9

Quemeneur T, Noel LH, Kyndt X, Droz D, Fleury D, Binaut R, Lemaitre V, Gobert P, Vanhille P (2005) Thrombotic microangiopathy in adult Still’s disease. Scand J Rheumatol 34(5):399–403. https://doi.org/10.1080/03009740510026689

Rawal S, Einbinder Y, Rubin L, Perl J, Trinkaus M, Teitel J, Pavenski K (2014) Thrombotic microangiopathy in a patient with adult-onset Still’s disease. Transfusion 54(11):2983–2987. https://doi.org/10.1111/trf.12708

Lee WS, Yoo WH (2014) Rituximab for refractory adult-onset Still’s disease with thrombotic microangiopathy. Rheumatology (Oxford) 53(9):1717–1718. https://doi.org/10.1093/rheumatology/keu027

Gopal M, Cohn CD, McEntire MR, Alperin JB (2009) Thrombotic thrombocytopenic purpura and adult onset Still’s disease. Am J Med Sci 337(5):373–376. https://doi.org/10.1097/MAJ.0b013e318191436e

Mulders-Manders C, Molenaar F, Baas M, Simon A (2015) Successful kidney transplantation during anakinra treatment without complications. Pediat Rheumatol. https://doi.org/10.1186/1546-0096-13-s1-p193

Kuo HL, Huang DF, Lee AF (2002) Thrombotic microangiopathy in a patient with adult onset Still’s disease. J Clin Rheumatol 8(5):276–280. https://doi.org/10.1097/00124743-200210000-00010

Perez MG, Rodwig FR Jr (2003) Chronic relapsing thrombotic thrombocytopenic purpura in adult onset Still's disease. South Med J 96(1):46–49. https://doi.org/10.1097/01.Smj.0000047763.56451.F0

Arulkumaran N, Reitbock P, Halliday K, Onwubalili J, Jayasena D, Dupont PJ (2010) Adult-onset Still’s disease associated with collapsing glomerulopathy. NDT Plus 3(1):54–56. https://doi.org/10.1093/ndtplus/sfp114

Bennett AN, Peterson P, Sangle S, Hangartner R, Abbs IC, Hughes GR, D’Cruz DP (2004) Adult onset Still’s disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 43(6):795–799. https://doi.org/10.1093/rheumatology/keh172

Izzedine H, Brocheriou I, Martinez V, Camous L, Guillemont MC, Deray G (2007) Fever, nephrotic syndrome, and rapidly progressive renal failure. Kidney Int 72(5):651–656. https://doi.org/10.1038/sj.ki.5002298

Kumar S, Sheaff M, Yaqoob M (2004) Collapsing glomerulopathy in adult still’s disease. Am J Kidney Dis 43(5):e4-10. https://doi.org/10.1053/j.ajkd.2003.11.025

Orentas M, Patel N, Rodby R, Hassan S (2022) The association between adult-onset Still’s disease and collapsing glomerulopathy: a case report. J Med Case Rep 16(1):370. https://doi.org/10.1186/s13256-022-03606-1

Aydin Z, Akarsu O, Gursu M, Uzun S, Karadag S, Tayfur F, Cagatay Y, Ozturk S, Kilicaslan I, Kazancioglu R (2010) Co-existence of adult-onset still's disease and IgA nephropathy/Eriskin still hastaligi ve IgA nefropatisi birlikteligi. The Medical Bulletin of Haseki:92+

Kang JH (2022) IgA nephropathy in adult-onset Still’s disease after tocilizumab treatment: a case report. Int Urol Nephrol 54(5):1167–1168. https://doi.org/10.1007/s11255-021-02956-x

Sayegh J, Besson V, Lavigne C, Croue A, Augusto JF (2011) Necrotizing crescentic immunoglobulin A glomerulonephritis in adult-onset Still’s disease. Clin Exp Nephrol 15(6):978–979. https://doi.org/10.1007/s10157-011-0546-6

Wendling D, Hory B, Blanc D (1990) Adult Still’s disease and mesangial glomerulonephritis. Report of two cases Clinical rheumatology 9(1):95–99. https://doi.org/10.1007/BF02030252

Amini M, Hakemi M, Saddadi F, Shahram F (2011) Stills disease and nephrotic range proteinuria. J Kidney Dis 5(Suppl 2):54

Eardley KS, Raza K, Adu D, Situnayake RD (2001) Gold treatment, nephrotic syndrome, and multi-organ failure in a patient with adult onset Still’s disease. Ann Rheum Dis 60(1):4–5. https://doi.org/10.1136/ard.60.1.4

El Mezouar I, Abourazzak FZ, Ghani N, Harzy T (2014) An unusual manifestation in a patient with adult-onset Still’s disease: Minimal glomerular lesion. Eur J Rheumatol 1(3):123–124. https://doi.org/10.5152/eurjrheumatol.2014.027

Babacan T, Onat AM, Pehlivan Y, Comez G, Karakok M (2010) Successful treatment of refractory adult Still’s disease and membranous glomerulonephritis with infliximab. Clin Rheumatol 29(4):423–426. https://doi.org/10.1007/s10067-009-1331-8

ShrutiShettigar SKG, Bobart SA (2022) Membranous Nephropathy in the Setting of Adult-Onset Still Disease: A Rare Association [Abstract]. J Am Soc Nephrol 33:193

Thonhofer R, Soleiman A, Kriessmayr M, Thonhofer U, Wipfler E, Gaugg M, Eder S, Erlacher L (2006) Decrease of proteinuria in a patient with adult-onset Still’s disease and glomerulonephritis after anti-TNFalpha therapy. Scand J Rheumatol 35(6):485–488. https://doi.org/10.1080/03009740600844688

Scholtze D, Varga Z, Imhof A (2011) Post-infection immunocomplex glomerulonephritis and Legionnaires’ disease in a patient with adult Still’s disease during treatment with interleukin 1 receptor antagonist anakinra: a case report. J Med Case Reports 5(1):299. https://doi.org/10.1186/1752-1947-5-299

Zarse CHT, Mahendraker N, Ezra N, Wolverton S, Phillips C, Blakley M, Jacobs M, Hellman R (2014) Resolution of Aki with Anakinra in Adult Onset Still’s Disease and Secondary Hemophagocytic L Ymphohistiocytosis. Ame J Kidney Dis. https://doi.org/10.1053/j.ajkd.2014.01.409

Betancur J-F, Navarro E-P, Echeverry A, Moncada PA, Cañas CA, Tobón GJ (2015) Hyperferritinemic syndrome: Still’s disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients. Clin Rheumatol 34(11):1989–1992. https://doi.org/10.1007/s10067-015-3040-9

Saito K, Temmoku J, Sumichika Y, Yoshida S, Takano E, Watanabe S, Matsumoto H, Fujita Y, Matsuoka N, Asano T, Sato S, Watanabe H, Migita K (2023) Adult-onset Still’s Disease with Acute Kidney Injury Requiring Hemodialysis: A Case Report and Literature Review. Intern Med 62(19):2901–2906. https://doi.org/10.2169/internalmedicine.1026-22

Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD (1992) Adult onset Still’s disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis 51(4):529–532. https://doi.org/10.1136/ard.51.4.529

Carron PL, Cartier JC, Truche AS, Brunelle C, Cartier J, Malvezzi P, Ponard D (2013) Complement alternative pathway activation in the course of thrombotic microangiopathy associated with adult-onset Still’s disease. Transfus Apher Sci 49(3):533–534. https://doi.org/10.1016/j.transci.2013.02.040

Sugimoto T, Yasuda M, Sakaguchi M, Osawa N, Tanaka Y, Uzu T, Kashiwagi A, Araki H, Isono M (2008) Hyponatraemia due to renal proximal tubule dysfunction in a patient with adult-onset Still’s disease. QJM 101(2):163–164. https://doi.org/10.1093/qjmed/hcm141

Anders HJ, Vielhauer V (2011) Renal co-morbidity in patients with rheumatic diseases. Arthritis Res Ther 13(3):222. https://doi.org/10.1186/ar3256

Wendling D, Humbert P, Hory B, Blanc D, Dupond JL, Guidet M (1989) The kidney in Still’s disease in adults. Rev Rhum Mal Osteoartic 56(4):325–327

Benjamin O, Goyal A, Lappin SL (2024) Disease-modifying antirheumatic drugs (DMARD). StatPearls, StatPearls Publishing LLC, Treasure Island (FL)

Gilani ST, Khan DA, Khan FA, Ahmed M (2012) Adverse effects of low dose methotrexate in rheumatoid arthritis patients. J Coll Physicians Surg Pak 22(2):101–104

Schiff MH, Whelton A (2000) Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30(3):196–208. https://doi.org/10.1053/sarh.2000.16641

Markowitz GS, Nasr SH, Stokes MB, D’Agati VD (2010) Treatment with IFN-alpha, -beta, or -gamma is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5(4):607–615. https://doi.org/10.2215/CJN.07311009

Taniguchi Y, Yorioka N, Kumagai J, Katsutani M, Kuratsune M, Amimoto D, Yamakido M (1999) Interleukin-6 localization and the prognosis of IgA nephropathy. Nephron 81(1):94–98. https://doi.org/10.1159/000045254

Mittal T, Rathi M (2014) Rheumatological diseases and kidneys: a nephrologist’s perspective. Int J Rheum Dis 17(8):834–844. https://doi.org/10.1111/1756-185X.12424